Anti Coag Special Populations Flashcards
CKD Dose Adjust of Renally Elim PARENTERAL Anti coags : Dalteparin
-If CrCL < 30 mL/min What do u adjust the dose to?
avoid
Enoxaparin :
-If CrCL 20-30 mL/min?
-If CrCL < 20 mL/min or on dialysis?
-Hospitalized pt’s can use (Enox)?
1 mg/kg SQ daily
UFH is preferred !
-Hospitalized pt’s can use 0.7 mg/kg SQ daily + trough anti-Xa levels
Bivalirudin :
-If CrCL 30-60 mL/min
-If CrCL 10-29 mL/min or CVVHD?
-If IHD?
These are ____ doses, adjust rate per ??
0.08 mg/kg/hr
0.05 mg/kg/hr
0.04 mg/kg/hr
starting, protocol and aPTT
Fondaparinux :
CrCl<30 mL/min
-What can u use to help guide therapy in CKD stage 3?
-What about ckd stage 4 or 5 ?
AVOID IN VTE
use antiXa levels
AVOID in CKD stages 4 and 5
Whats ur goal anti-Xa trough when using Enoxaparin in renally adjusted pt’s?
< 0.4 IU/mL
CKD Dose adjustments of DOACS When Treating VTE : DABIGATRAN
For CrCL < 30 mL/min?
For CrCL < 50 mL/min with concomitant use of PGP inhibitors,(Ketoconazole, quinidine, verapamil, erythro, cyclosporine, amio, dronedarone) ?
DONT USE
avoid coadmin
A. RIVAROXABAN when TREATING VTE :
CrCL < 15 mL/min?
B. APIXABAN ADJUSTMENT?
DONT USE
NO RENAL DOSE ADJ. 10 mg po bid for 7 days then 5 mg PO BID afterwards
C. EDOXABAN
For CrCL 15-50 mL/min or weight <= 60 kg or who use certain PGP inhibitors?
For CrCL < 15 mL/min?
30 mg PO DAILY
dont use for tx of VTE
What are some high risk patient groups that may require LMWH monitoring with Anti-Xa levels? (4)
Obesity
renal impairment with CrCL < 30
Elderly + Children
Cancer pt’s
OBESITY BMI > 40 kg/m^2 : For each state the prophylaxis dosing and the therapeutic dosing adjustments
- UFH
- LMWH
- Fondaparinux
- DTI’s
- Warfarin
- Consider higher doses like 7500 units SQ TID or 10k units sq BID if weight > 120 kg
-Can follow anti Xa levels
No adjust needed
- 0.5 mg/kg SQ daily or 30% incr from standard dose + anti Xa monitoring
for VTE : 0.75 mg/kg SQ BID (use actual body weight) + anti Xa monitoring
- no recs
-fixed dose of 10 mg SQ daily for weight > 100 kg for VTE. Can use anti Xa to monitor - n/a
use actual body weight. titrate to effect based on aPTT
- n/a
may require higher initial dose at start but titrate towards INR endpoint
Obesity and DOACs :
Which drugs are appropriate options regardless of high BMI and weight for tx of VTE?
Suggest not to use the following for VTE tx in obese pt’s?
apixaban or rivaroxaban
Dabigatran, edoxaban, Betrixaban
Indications for using Anti-thrombotics In pregnancy? (Pre existing Disease)
-Acute VTE
* Chronic VTE
* Atrial fibrillation
* Valvular and structural
heart disease
* Ischemic stroke
* Acute coronary syndromes
* Peripheral artery occlusive
disease
Indications for using Anti-thrombotics In pregnancy? (Pre existing risk factors)
Hypercoagulable conditions such as AT deficiency or antiphospholipid syndrome
AntiCoag Recc in Pregnancy :
Which 2 agents can u use, and which 2 should u avoid?
LMWH : preferred. doesnt cross placenta, not transferred through breast milk
UFH : yes as alternative to LMWH. Preferred in pt’s with severe renal issues, doesnt cross placenta. Long term use –> Osteoporosis
Vitamin K antags (Avoid during preg if u can because it’s a teratogen and MAY Cross placenta)
DOACs (avoid during preg). Potential risk for fetal bleeding
LMWH in Pregnancy :
-What kind of monitoring to consider?
-In preg women with severe renal dysfunction?
-What kind of preparations to use?
For epidural catheter placement to minimize risk of spinal hematoma :
-How long do u have to wait between last therapeutic LMWH injection?
-How long must u wait between last PROPHYLACTIC LMWH injection?
When should pregnant women consider switching to UFH?
-Anti Xa
-UFH
-Preservative free (pre filled syringes)
- > = 24 hrs
- > = 12 hrs
36-37 weeks gestation